Gantenerumab in Early Alzheimer's Disease. Reply

N Engl J Med. 2024 Feb 29;390(9):867. doi: 10.1056/NEJMc2314291.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Alzheimer Disease* / drug therapy
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Humans

Substances

  • gantenerumab
  • Antibodies, Monoclonal, Humanized